Impact of the COVID-19 pandemic on fertility preservation activities in France: a survey by the Groupe de Recherche et d'Etude sur la Conservation Ovarienne et Testiculaire (GRECOT; Group for Research and Studies on Ovarian and Testicular Preservation) - 25/02/22
, PIRELLO Olivier 3, CLAIRAZ Philippe 4, POIROT Catherine 5, 6, 7for the
GRECOT COVID GROUP
Bienvenue sur EM-consulte, la référence des professionnels de santé.
Article gratuit.
Connectez-vous pour en bénéficier!
Cet article a été publié dans un numéro de la revue, cliquez ici pour y accéder
Highlights |
• | Fertility preservation activities were affected by the COVID-19 crisis |
• | During the lockdown of spring 2020 it was not possible to manage some patients |
• | 8.35% of patients lost all chance of fertility preservation during the lockdown |
Abstract |
Bachground: To study the repercussions of the COVID-19 pandemic for fertility preservation activities in France
Basic procedures: A questionnaire was sent to all the fertility preservation centres, requesting, for fertility preservation techniques (gamete and gonadal tissue preservation), the number of patients managed before, during and after the lockdown, and the number of patients who were not able to have access to these techniques and thus suffered definitive losses of fertility, during the lockdown period in spring 2020.
Main findings: Fertility preservation activities in France did not cease entirely during the lockdown, but a 42.6% decrease in activity was observed.
After lockdown, the levels of sperm, testicular and ovarian tissue cryopreservation returned to pre-lockdown levels (95.2%). The restoration of activity was partial only for oocyte freezing, which reached a level 56.8% that before lockdown. In total, 45 patients (8.35%) lost all chance of fertility preservation during the lockdown period.
Principal conclusions: In France, fertility preservation activities were significantly affected by the lockdown in spring 2020 linked to the COVID-19 pandemic.
Le texte complet de cet article est disponible en PDF.Keywords : fertility preservation, COVID-19, cryopreservation
Plan
| GRECOT COVID GROUP: ALTER Laura (CHI Poissy Saint Germain en Laye), BARRAUD-LANGE Virginie (CHU Cochin, Paris), BENHAIM Annie (CHU Caen), BOURY Arnaud (Bioxa Reims), BRINGER-DEUTSCH Sophie (CHU Montpellier), BRUGNON Florence (CHU Clermont-Ferrand), DAUDIN Myriam (CHU Toulouse), DELEPINE-PANISSET Béatrice (CHU Reims), DENOAL-ZAD Christine (CHU Caen), FRAPSAUCE Cynthia (CHU Tours), GATIMEL Nicolas (CHU Toulouse), GIORGETTI Claude (IRM Marseille), GUILLEMAIN Catherine (CHU Marseille), HENNEBICQ Sylviane (CHU Grenoble), HESTER Laeticia (CHU Antoine Beclère, Clamart), KELLER Laura (CHU Lille), KOSCINSKI Isabelle (CHU Nancy), LEFRANC Elodie (CHU Amiens), LICHTBAU Isabelle (CHU Strasbourg), LORNAGE Jacqueline (CHU Lyon), MAY PANLOUP Pascale (CHU Angers), MERY Lionel (CHU St Etienne), MIRALLIE Sophie (CHU Nantes), PAPAXANTHOS Aline (CHU Bordeaux), PECH Jean Christophe (CHU Limoges), PRADES Marie (CHU Tenon, Paris), RIVES-FERRAILLE Aurélie (CHU Rouen), SCHMITT Françoise (CHR Mulhouse), THIBAULT Emmanuelle (CHU Nice) |
Bienvenue sur EM-consulte, la référence des professionnels de santé.